Articles by John

I have been building forums to promote the life sciences community for over 10 years. I enjoy exploring the issues, individuals and companies impacting the life/med/health tech community, and celebrating the innovators, entrepreneurs and policy makers who are actively working to build the community.


Naurex Raises $80m in Series C Financing Round

Naurex Inc., a biopharmaceutical company leveraging its uniqueplatform to develop novel drugs for diseases of the central nervous system (CNS), today announced thecompletion of an $80 million Series C financing round. New investors participating in the round include Cowen Investments, EcoR1 Capital, Goudy Park Capital,Portola Capital Partners and Sabby Capital. Existing investors also participated in…


Takeda gets a ‘breakthrough’ tag for PhIII rare disease drug

With its bottom line getting squeezed and big budget cuts looming, Takeda and its new president, Christophe Weber, issued some upbeat news today for a change. The FDA has branded its top late-stage drug prospect ixazomib (MLN9708)–a multiple myeloma treatment designed to succeed the top-selling blockbuster Velcade–as a “breakthrough” therapy deserving VIP status with regulators.


2014 Digital Health Investments Break $3B

Investments in digital health companies this year has risen to $3 billion — and the year is only three quarters over. By the midyear point, 2014 digital health investments had already eclipsed 2013 investments. And investments have continue to accelerate since then. The total for this year is now twice the full-year total for 2013, according to a new…

Copyright © 2014 WhiteCityNews, All rights reserved.